{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:27:45Z","timestamp":1790033265093,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T00:00:00Z","timestamp":1476748800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["15-04-05606"],"award-info":[{"award-number":["15-04-05606"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["16-34-00200"],"award-info":[{"award-number":["16-34-00200"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s12035-016-0190-y","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T03:10:56Z","timestamp":1476760256000},"page":"6775-6784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Transcriptome Profile Changes in Mice with MPTP-Induced Early Stages of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"54","author":[{"given":"Anelya Kh.","family":"Alieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Filatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Kolacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita M.","family":"Rudenok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr A.","family":"Slominsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail V.","family":"Ugrumov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Shadrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"issue":"2","key":"190_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1212\/01.WNL.0000149511.19487.44","volume":"64","author":"BA Racette","year":"2005","unstructured":"Racette BA, Tabbal SD, Jennings D, Good L, Perlmutter JS, Evanoff B (2005) Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology 64(2):230\u2013235. doi: 10.1212\/01.WNL.0000149511.19487.44","journal-title":"Neurology"},{"issue":"2","key":"190_CR2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mds.10087","volume":"17","author":"LE Claveria","year":"2002","unstructured":"Claveria LE, Duarte J, Sevillano MD, Perez-Sempere A, Cabezas C, Rodriguez F, de Pedro-Cuesta J (2002) Prevalence of Parkinson\u2019s disease in Cantalejo, Spain: a door-to-door survey. Movement Disorders : Official Journal of the Movement Disorder Society 17(2):242\u2013249","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"issue":"6","key":"190_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/pds.624","volume":"10","author":"DA Vijver van de","year":"2001","unstructured":"van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A (2001) Estimation of incidence and prevalence of Parkinson\u2019s disease in the elderly using pharmacy records. Pharmacoepidemiol Drug Saf 10(6):549\u2013554. doi: 10.1002\/pds.624","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"190_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-0404.2004.00348.x","volume":"111","author":"DK Chan","year":"2005","unstructured":"Chan DK, Cordato D, Karr M, Ong B, Lei H, Liu J, Hung WT (2005) Prevalence of Parkinson\u2019s disease in Sydney. Acta Neurol Scand 111(1):7\u201311. doi: 10.1111\/j.1600-0404.2004.00348.x","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"190_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2188\/jea.12.403","volume":"12","author":"S Morioka","year":"2002","unstructured":"Morioka S, Sakata K, Yoshida S, Nakai E, Shiba M, Yoshimura N, Hashimoto T (2002) Incidence of Parkinson disease in Wakayama, Japan. Journal of Epidemiology \/ Japan Epidemiological Association 12(6):403\u2013407","journal-title":"Journal of Epidemiology \/ Japan Epidemiological Association"},{"issue":"10","key":"190_CR6","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/hmg\/6.10.1687","volume":"6","author":"RL Nussbaum","year":"1997","unstructured":"Nussbaum RL, Polymeropoulos MH (1997) Genetics of Parkinson\u2019s disease. Hum Mol Genet 6(10):1687\u20131691","journal-title":"Hum Mol Genet"},{"key":"190_CR7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"key":"190_CR8","first-page":"217","volume":"1","author":"MR Cookson","year":"2008","unstructured":"Cookson MR, Hardy J, Lewis PA (2008) Genetic neuropathology of Parkinson\u2019s disease. Int J Clin Exp Pathol 1:217\u2013231","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"190_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/nau.20371","volume":"26","author":"CJ Fowler","year":"2007","unstructured":"Fowler CJ (2007) Update on the neurology of Parkinson\u2019s disease. Neurourol Urodyn 26(1):103\u2013109. doi: 10.1002\/nau.20371","journal-title":"Neurourol Urodyn"},{"issue":"R1","key":"190_CR10","doi-asserted-by":"publisher","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","volume":"18","author":"S Lesage","year":"2009","unstructured":"Lesage S, Brice A (2009) Parkinson\u2019s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18(R1):R48\u2013R59. doi: 10.1093\/hmg\/ddp012","journal-title":"Hum Mol Genet"},{"key":"190_CR11","doi-asserted-by":"publisher","first-page":"489830","DOI":"10.1100\/2012\/489830","volume":"2012","author":"F Coppede","year":"2012","unstructured":"Coppede F (2012) Genetics and epigenetics of Parkinson\u2019s disease. Sci World J 2012:489830. doi: 10.1100\/2012\/489830","journal-title":"Sci World J"},{"issue":"Suppl 1","key":"190_CR12","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/S1353-8020(11)70022-0","volume":"18","author":"S Lesage","year":"2012","unstructured":"Lesage S, Brice A (2012) Role of mendelian genes in \u201csporadic\u201d Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S66\u2013S70. doi: 10.1016\/S1353-8020(11)70022-0","journal-title":"Parkinsonism Relat Disord"},{"key":"190_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0079-6123(10)84007-5","volume":"184","author":"SH Fox","year":"2010","unstructured":"Fox SH, Brotchie JM (2010) The MPTP-lesioned non-human primate models of Parkinson\u2019s disease. Past, present, and future. Prog Brain Res 184:133\u2013157. doi: 10.1016\/S0079-6123(10)84007-5","journal-title":"Prog Brain Res"},{"issue":"4","key":"190_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.pneurobio.2010.09.001","volume":"92","author":"IS Pienaar","year":"2010","unstructured":"Pienaar IS, Gotz J, Feany MB (2010) Parkinson\u2019s disease: insights from non-traditional model organisms. Prog Neurobiol 92(4):558\u2013571. doi: 10.1016\/j.pneurobio.2010.09.001","journal-title":"Prog Neurobiol"},{"issue":"3","key":"190_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11910-012-0270-y","volume":"12","author":"B Byers","year":"2012","unstructured":"Byers B, Lee HL, Reijo Pera R (2012) Modeling Parkinson\u2019s disease using induced pluripotent stem cells. Current Neurology and Neuroscience Reports 12(3):237\u2013242. doi: 10.1007\/s11910-012-0270-y","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"4","key":"190_CR16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/neur.1996.0041","volume":"5","author":"DC German","year":"1996","unstructured":"German DC, Nelson EL, Liang CL, Speciale SG, Sinton CM, Sonsalla PK (1996) The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. Neurodegeneration : A Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration 5(4):299\u2013312","journal-title":"Neurodegeneration : A Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration"},{"issue":"Suppl 2","key":"190_CR17","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/j.parkreldis.2008.04.012","volume":"14","author":"GE Meredith","year":"2008","unstructured":"Meredith GE, Totterdell S, Potashkin JA, Surmeier DJ (2008) Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism Relat Disord 14(Suppl 2):S112\u2013S115. doi: 10.1016\/j.parkreldis.2008.04.012","journal-title":"Parkinsonism Relat Disord"},{"issue":"8\u20139","key":"190_CR18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","volume":"103","author":"M Gerlach","year":"1996","unstructured":"Gerlach M, Riederer P (1996) Animal models of Parkinson\u2019s disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm 103(8\u20139):987\u20131041","journal-title":"J Neural Transm"},{"issue":"4587","key":"190_CR19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science (New York, NY) 219(4587):979\u2013980","journal-title":"Science (New York, NY)"},{"issue":"2","key":"190_CR20","first-page":"135","volume":"16","author":"S Przedborski","year":"2000","unstructured":"Przedborski S, Jackson-Lewis V, Djaldetti R, Liberatore G, Vila M, Vukosavic S, Almer G (2000) The parkinsonian toxin MPTP: action and mechanism. Restor Neurol Neurosci 16(2):135\u2013142","journal-title":"Restor Neurol Neurosci"},{"issue":"3","key":"190_CR21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","volume":"4","author":"V Jackson-Lewis","year":"1995","unstructured":"Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration: A Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration 4(3):257\u2013269","journal-title":"Neurodegeneration: A Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration"},{"issue":"19","key":"190_CR22","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1073\/pnas.0609874104","volume":"104","author":"C Perier","year":"2007","unstructured":"Perier C, Bove J, Wu DC, Dehay B, Choi DK, Jackson-Lewis V, Rathke-Hartlieb S, Bouillet P et al (2007) Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson\u2019s disease. Proc Natl Acad Sci U S A 104(19):8161\u20138166. doi: 10.1073\/pnas.0609874104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"190_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","volume":"17","author":"RD Prediger","year":"2010","unstructured":"Prediger RD, Aguiar AS Jr, Rojas-Mayorquin AE, Figueiredo CP, Matheus FC, Ginestet L, Chevarin C, Bel ED et al (2010) Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson\u2019s disease. Neurotox Res 17(2):114\u2013129. doi: 10.1007\/s12640-009-9087-0","journal-title":"Neurotox Res"},{"issue":"2","key":"190_CR24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3940(87)90134-0","volume":"82","author":"JC Linder","year":"1987","unstructured":"Linder JC, Klemfuss H, Groves PM (1987) Acute ultrastructural and behavioral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice. Neurosci Lett 82(2):221\u2013226","journal-title":"Neurosci Lett"},{"key":"190_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuroscience.2011.03.007","volume":"181","author":"MV Ugrumov","year":"2011","unstructured":"Ugrumov MV, Khaindrava VG, Kozina EA, Kucheryanu VG, Bocharov EV, Kryzhanovsky GN, Kudrin VS, Narkevich VB et al (2011) Modeling of presymptomatic and symptomatic stages of parkinsonism in mice. Neuroscience 181:175\u2013188. doi: 10.1016\/j.neuroscience.2011.03.007","journal-title":"Neuroscience"},{"issue":"7","key":"190_CR26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0024-3205(87)90180-9","volume":"41","author":"E Sundstrom","year":"1987","unstructured":"Sundstrom E, Luthman J, Jonsson G, Goldstein M (1987) Determination of monoamines by use of liquid chromatography with electrochemical detection in the study of selective monoamine neurotoxins. Life Sci 41(7):857\u2013860","journal-title":"Life Sci"},{"issue":"1","key":"190_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1134\/s0012496614030041","volume":"456","author":"AA Kolacheva","year":"2014","unstructured":"Kolacheva AA, Kozina EA, Volina EV, Ugryumov MV (2014) Time course of degeneration of dopaminergic neurons and respective compensatory processes in the nigrostriatal system in mice. Doklady Biological Sciences : Proceedings of the Academy of Sciences of the USSR, Biological Sciences Sections \/ Translated from Russian 456(1):160\u2013164. doi: 10.1134\/s0012496614030041","journal-title":"Doklady Biological Sciences : Proceedings of the Academy of Sciences of the USSR, Biological Sciences Sections \/ Translated from Russian"},{"issue":"1\u20132","key":"190_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jns.2014.03.028","volume":"340","author":"EA Kozina","year":"2014","unstructured":"Kozina EA, Khakimova GR, Khaindrava VG, Kucheryanu VG, Vorobyeva NE, Krasnov AN, Georgieva SG, Kerkerian-Le Goff L et al (2014) Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism. J Neurol Sci 340(1\u20132):198\u2013207. doi: 10.1016\/j.jns.2014.03.028","journal-title":"J Neurol Sci"},{"key":"190_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-9936-9","author":"GR Khakimova","year":"2016","unstructured":"Khakimova GR, Kozina EA, Kucheryanu VG, Ugrumov MV (2016) Reversible pharmacological induction of motor symptoms in MPTP-treated mice at the presymptomatic stage of parkinsonism: potential use for early diagnosis of Parkinson\u2019s disease. Mol Neurobiol. doi: 10.1007\/s12035-016-9936-9","journal-title":"Mol Neurobiol"},{"key":"190_CR30","unstructured":"National Research Council (2011). Guide for the care and use of laboratory animals. (8th Edition). Washington, DC: The National Academies Press.\u00a0"},{"issue":"20","key":"190_CR31","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1093\/nar\/gni176","volume":"33","author":"O Suslov","year":"2005","unstructured":"Suslov O, Steindler DA (2005) PCR inhibition by reverse transcriptase leads to an overestimation of amplification efficiency. Nucleic Acids Res 33(20):e181. doi: 10.1093\/nar\/gni176","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"190_CR32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physiolgenomics.2000.2.3.143","volume":"2","author":"JA Warrington","year":"2000","unstructured":"Warrington JA, Nair A, Mahadevappa M, Tsyganskaya M (2000) Comparison of human adult and fetal expression and identification of 535 housekeeping\/maintenance genes. Physiol Genomics 2(3):143\u2013147","journal-title":"Physiol Genomics"},{"issue":"1","key":"190_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44\u201357. doi: 10.1038\/nprot.2008.211","journal-title":"Nat Protoc"},{"issue":"1","key":"190_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W Huang da","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37(1):1\u201313. doi: 10.1093\/nar\/gkn923","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"190_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods 25(4):402\u2013408. doi: 10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"23","key":"190_CR36","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1111\/febs.12335","volume":"280","author":"PM Antony","year":"2013","unstructured":"Antony PM, Diederich NJ, Kruger R, Balling R (2013) The hallmarks of Parkinson\u2019s disease. FEBS J 280(23):5981\u20135993. doi: 10.1111\/febs.12335","journal-title":"FEBS J"},{"issue":"6","key":"190_CR37","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67(6):715\u2013725. doi: 10.1002\/ana.21995","journal-title":"Ann Neurol"},{"issue":"11","key":"190_CR38","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/j.neurobiolaging.2013.05.017","volume":"34","author":"NW Sterling","year":"2013","unstructured":"Sterling NW, Du G, Lewis MM, Dimaio C, Kong L, Eslinger PJ, Styner M, Huang X (2013) Striatal shape in Parkinson\u2019s disease. Neurobiol Aging 34(11):2510\u20132516. doi: 10.1016\/j.neurobiolaging.2013.05.017","journal-title":"Neurobiol Aging"},{"key":"190_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coph.2014.10.011","volume":"20c","author":"F Gardoni","year":"2015","unstructured":"Gardoni F, Di Luca M (2015) Targeting glutamatergic synapses in Parkinson\u2019s disease. Curr Opin Pharmacol 20c:24\u201328. doi: 10.1016\/j.coph.2014.10.011","journal-title":"Curr Opin Pharmacol"},{"key":"190_CR40","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3389\/fpsyg.2014.01301","volume":"5","author":"T Macpherson","year":"2014","unstructured":"Macpherson T, Morita M, Hikida T (2014) Striatal direct and indirect pathways control decision-making behavior. Front Psychol 5:1301. doi: 10.3389\/fpsyg.2014.01301","journal-title":"Front Psychol"},{"issue":"3","key":"190_CR41","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tins.2014.12.009","volume":"38","author":"BH Hunn","year":"2015","unstructured":"Hunn BH, Cragg SJ, Bolam JP, Spillantini MG, Wade-Martins R (2015) Impaired intracellular trafficking defines early Parkinson\u2019s disease. Trends Neurosci 38(3):178\u2013188. doi: 10.1016\/j.tins.2014.12.009","journal-title":"Trends Neurosci"},{"key":"190_CR42","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/1531-8257(199909)14:5<764::AID-MDS1008>3.0.CO;2-W","volume":"14","author":"P Barbanti","year":"1999","unstructured":"Barbanti P, Fabbrini G, Ricci A, Cerbo R, Bronzetti E, Caronti B, Calderaro C, Felici L et al (1999) Increased expression of dopamine receptors on lymphocytes in Parkinson\u2019s disease. Movement Disorders : Official Journal of the Movement Disorder Society 14:764\u2013771","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"issue":"7","key":"190_CR43","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1179\/174313209X383259","volume":"31","author":"FR Buttarelli","year":"2009","unstructured":"Buttarelli FR, Capriotti G, Pellicano C, Prosperi D, Circella A, Festa A, Giovannelli M, Tofani A et al (2009) Central and peripheral dopamine transporter reduction in Parkinson\u2019s disease. Neurol Res 31(7):687\u2013691","journal-title":"Neurol Res"},{"key":"190_CR44","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1212\/WNL.46.3.791","volume":"46","author":"Y Nagai","year":"1996","unstructured":"Nagai Y, Ueno S, Saeki Y, Soga F, Hirano M, Yanagihara T (1996) Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson\u2019s disease. Neurology 46:791\u2013795","journal-title":"Neurology"},{"issue":"2","key":"190_CR45","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s12035-012-8369-3","volume":"47","author":"M Ozansoy","year":"2013","unstructured":"Ozansoy M, Basak AN (2013) The central theme of Parkinson\u2019s disease: alpha-synuclein. Mol Neurobiol 47(2):460\u2013465. doi: 10.1007\/s12035-012-8369-3","journal-title":"Mol Neurobiol"},{"issue":"1","key":"190_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ajmg.b.10005","volume":"116b","author":"EP Noble","year":"2003","unstructured":"Noble EP (2003) D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. American Journal of Medical Genetics Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics 116b(1):103\u2013125. doi: 10.1002\/ajmg.b.10005","journal-title":"American Journal of Medical Genetics Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics"},{"issue":"15","key":"190_CR47","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2217\/pgs.12.149","volume":"13","author":"M Rieck","year":"2012","unstructured":"Rieck M, Schumacher-Schuh AF, Altmann V, Francisconi CL, Fagundes PT, Monte TL, Callegari-Jacques SM, Rieder CR et al (2012) DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson\u2019s disease patients. Pharmacogenomics 13(15):1701\u20131710. doi: 10.2217\/pgs.12.149","journal-title":"Pharmacogenomics"},{"issue":"2","key":"190_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12031-014-0276-9","volume":"53","author":"N Kaplan","year":"2014","unstructured":"Kaplan N, Vituri A, Korczyn AD, Cohen OS, Inzelberg R, Yahalom G, Kozlova E, Milgrom R et al (2014) Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson\u2019s disease. Journal of Molecular Neuroscience : MN 53(2):183\u2013188. doi: 10.1007\/s12031-014-0276-9","journal-title":"Journal of Molecular Neuroscience : MN"},{"issue":"2","key":"190_CR49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archneur.58.2.209","volume":"58","author":"CG Goetz","year":"2001","unstructured":"Goetz CG, Burke PF, Leurgans S, Berry-Kravis E, Blasucci LM, Raman R, Zhou L (2001) Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study. Arch Neurol 58(2):209\u2013213","journal-title":"Arch Neurol"},{"issue":"11","key":"190_CR50","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.WNL.0000068009.32067.A1","volume":"60","author":"R Kaiser","year":"2003","unstructured":"Kaiser R, Hofer A, Grapengiesser A, Gasser T, Kupsch A, Roots I, Brockmoller J (2003) L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism. Neurology 60(11):1750\u20131755","journal-title":"Neurology"},{"issue":"9","key":"190_CR51","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2217\/pgs.14.93","volume":"15","author":"AF Schumacher-Schuh","year":"2014","unstructured":"Schumacher-Schuh AF, Rieder CR, Hutz MH (2014) Parkinson\u2019s disease pharmacogenomics: new findings and perspectives. Pharmacogenomics 15(9):1253\u20131271. doi: 10.2217\/pgs.14.93","journal-title":"Pharmacogenomics"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-0190-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0190-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0190-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T14:26:56Z","timestamp":1568471216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-0190-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,18]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["190"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-0190-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,18]]}}}